These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31954199)

  • 1. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity.
    Fuglsang-Nielsen R; Rakvaag E; Vestergaard P; Hartmann B; Holst JJ; Hermansen K; Gregersen S; Starup-Linde J
    Bone; 2020 Apr; 133():115230. PubMed ID: 31954199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
    Westberg-Rasmussen S; Starup-Linde J; Hermansen K; Holst JJ; Hartmann B; Vestergaard P; Gregersen S
    Bone; 2017 Apr; 97():261-266. PubMed ID: 28126633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.
    Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endogenous GIP and GLP-1 in postprandial bone homeostasis.
    Helsted MM; Gasbjerg LS; Lanng AR; Bergmann NC; Stensen S; Hartmann B; Christensen MB; Holst JJ; Vilsbøll T; Rosenkilde MM; Knop FK
    Bone; 2020 Nov; 140():115553. PubMed ID: 32730920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.
    Skov-Jeppesen K; Christiansen CB; Hansen LS; Windeløv JA; Hedbäck N; Gasbjerg LS; Hindsø M; Svane MS; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1773-1780. PubMed ID: 38217866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metabolism and incretin hormones following glucose ingestion in young adults with pancreatic insufficient cystic fibrosis.
    Lei WS; Kilberg MJ; Zemel BS; Rubenstein RC; Harris C; Sheikh S; Kelly A; Kindler JM
    J Clin Transl Endocrinol; 2022 Dec; 30():100304. PubMed ID: 36110921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of 12-Weeks Whey Protein Supplements on Markers of Bone Turnover in Adults With Abdominal Obesity - A
    Fuglsang-Nielsen R; Rakvaag E; Vestergaard P; Hermansen K; Gregersen S; Starup-Linde J
    Front Endocrinol (Lausanne); 2022; 13():832897. PubMed ID: 35422766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preserved postprandial suppression of bone turnover markers, despite increased fasting levels, in postmenopausal women.
    Abildgaard J; Ploug T; Pedersen AT; Eiken P; Pedersen BK; Holst JJ; Hartmann B; Lindegaard B
    Bone; 2021 Feb; 143():115612. PubMed ID: 32853851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes.
    Dalsgaard NB; Gasbjerg LS; Helsted MM; Hansen LS; Hansen NL; Skov-Jeppesen K; Hartmann B; Holst JJ; Vilsbøll T; Knop FK
    Bone; 2023 May; 170():116687. PubMed ID: 36754130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeding and bone turnover in gastric bypass.
    Valderas JP; Padilla O; Solari S; Escalona M; González G
    J Clin Endocrinol Metab; 2014 Feb; 99(2):491-7. PubMed ID: 24276463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous GIP and GLP-2 inhibit nightly bone resorption in postmenopausal women: A preliminary study.
    Skov-Jeppesen K; Veedfald S; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
    Bone; 2021 Nov; 152():116065. PubMed ID: 34153529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.
    Skov-Jeppesen K; Svane MS; Martinussen C; Gabe MBN; Gasbjerg LS; Veedfald S; Bojsen-Møller KN; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
    Bone; 2019 Aug; 125():178-185. PubMed ID: 31100534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients With Type 2 Diabetes.
    Yu EW; Wewalka M; Ding SA; Simonson DC; Foster K; Holst JJ; Vernon A; Goldfine AB; Halperin F
    J Clin Endocrinol Metab; 2016 Feb; 101(2):714-22. PubMed ID: 26600045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia.
    Christensen MB; Lund A; Calanna S; Jørgensen NR; Holst JJ; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2018 Jan; 103(1):288-294. PubMed ID: 29099978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without Diabetes.
    Bergmann NC; Lund A; Gasbjerg LS; Jørgensen NR; Jessen L; Hartmann B; Holst JJ; Christensen MB; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2953-2960. PubMed ID: 30848791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes.
    Christensen MB; Lund AB; Jørgensen NR; Holst JJ; Vilsbøll T; Knop FK
    J Endocr Soc; 2020 Sep; 4(9):bvaa097. PubMed ID: 32904711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a whey protein pre-meal on bone turnover in participants with and without type 2 diabetes-A post hoc analysis of a randomised, controlled, crossover trial.
    Bjørnshave A; Lykkeboe S; Hartmann B; Holst JJ; Hermansen K; Starup-Linde J
    Diabet Med; 2021 Jun; 38(6):e14471. PubMed ID: 33259643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
    Hartmann B; Longo M; Mathiesen DS; Hare KJ; Jørgensen NR; Esposito K; Deacon CF; Vilsbøll T; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2023 Dec; 109(1):e259-e265. PubMed ID: 37466204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.